2Walash MI,Belal FF,El-Enany NM,et al.Synchronousfluorescence spectrofluorimetric method for the simultaneousdetermination of metoprolol and felodipine in combinedpharmaceutical preparation[J].Chem Cent J,2011,5(1):70.
3Evans WE,Relling MV.Pharmacogenomics:translatingfunctional genomics into rational therapeutics[J].Science,1999,286(5439):487-491.
5Kyungsoo P,Seong BJ,Tae DK,et al.The effect of beta1-adrenergic receptor gene polymorphism on prolongation ofcorrected QT interval during endotracheal intubation undersevoflurane anesthesia[J].Korean J Anesthesiol,2011,61(2):117-121.
6Mason DA,Moare JD,Green SA,et al.A gain-of-functionpolymorphism in a G-protien coupling domain of the humanbetal-adrenergic receptor[J].J Biol Chem,1999,274(18):12670-12674.
7Liu J,Liu ZQ,Tan ZR,et al.Gly389Arg polymorphism ofbetal-adrenergic receptor is associated with the cardiovascularresponse to metoprolol[J].Clin Pharmacol Ther,2003,74(4):372-379.
8Liu J,Liu ZQ,Yu BN,et al.Betal-Adrenergic receptorpolymorphisms influence the response to metoprololmonotherapy in patients with essential hypertension[J].ClinPharmacol Ther,2006,80(1):23-32.
9Evans WE,Meleod HL.Pharmacogenomics-drug disposition,drug targets,and side effects[J].N Engl J Med,2003,348(6):538-549.
10Holtbecker N,Fromm MF.Kroemer for induction of gut wallmetabolism[J].Drug Metab Dispos,1997,25(9):1107-1109.
